Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

371

LikeLikedUnlike

Episodes 271-285 of 337

Discovering Face Blindness: An Expert’s Perspective on Prosopagnosia
NeuroFrontiers
Discovering Face Blindness: An Expert’s Perspective on Prosopagnosia
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Jason Barton, MD, PhD, FRCP(C)
  Peer
Advances in Temporal Lobe Epilepsy Research
NeuroFrontiers
Advances in Temporal Lobe Epilepsy Research
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Sanjay Kumar, PhD
  Peer
Exploring Alzheimer’s Disease Risk Loci: 75 & Counting
NeuroFrontiers
Exploring Alzheimer’s Disease Risk Loci: 75 & Counting
AI in Neurology: What Tools Are Emerging?
NeuroFrontiers
AI in Neurology: What Tools Are Emerging?
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Mark Mintz, MD
  Peer
Clinical Considerations for the Treatment of Schizophrenia
NeuroFrontiers
Clinical Considerations for the Treatment of Schizophrenia
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Craig Chepke, MD, FAPA
  Peer
Investigating the Link Between Hypertension Medications & Dementia
NeuroFrontiers
Investigating the Link Between Hypertension Medications & Dementia
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Zachary Marcum, PharmD, PhD
  Peer
advertisement
B-Cell Therapy: When Is It Right for Our MS Patients?
NeuroFrontiers
B-Cell Therapy: When Is It Right for Our MS Patients?
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Andrew Chan, MD
  Peer
Alzheimer’s Disease: What’s The Latest Research?
NeuroFrontiers
Alzheimer’s Disease: What’s The Latest Research?
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Peter Whitehouse, MD, PhD
  Peer
- Daniel George, MSc, PhD
  Peer
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
NeuroFrontiers
Diving into the Debate Surrounding Aducanumab for Alzheimer’s
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Peter Whitehouse, MD, PhD
  Peer
Investigating the Impact of Mobile Stroke Units
NeuroFrontiers
Investigating the Impact of Mobile Stroke Units
Investigating the Potential Link Between Epstein-Barr Virus & MS
NeuroFrontiers
Investigating the Potential Link Between Epstein-Barr Virus & MS
Keys to Closing the Gender Gap in Stroke Trials
NeuroFrontiers
Keys to Closing the Gender Gap in Stroke Trials
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Cheryl Carcel, MD, PhD
  Peer
advertisement
Spinal Cord Injuries: How a New Implant Is Getting People Up & Walking
NeuroFrontiers
Spinal Cord Injuries: How a New Implant Is Getting People Up & Walking
Diagnosing Mental Illness with the Perspectives Approach
NeuroFrontiers
Diagnosing Mental Illness with the Perspectives Approach
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Margaret Chisolm, MD
  Peer
Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics
NeuroFrontiers
Reducing Relapse for Schizophrenia Patients: A Look at LAI Antipsychotics
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Jose Rubio, MD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended